longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

VanEck Biotech ETF

BBH

----
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends
LongbridgeAI

About

VanEck ETF Trust - VanEck Biotech ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, biotechnology sectors. The fund invests in growth and value stocks of companies across diversified market capitalization.

Name
VanEck Biotech ETF
Index tracked
MVIS US Listed Biotech 25 NR USD
Type
Equity
Expense ratio
0.35%
Management fee
0.35%
Dividend policy
Annually
NAV
USD 230.8 (09/15/2026)
Issued units
2.01M (09/15/2026)
Listing date
Dec 20, 2011
Sponsor
VanEck
Custodian
State Street Bank and Trust Company

ETF Documents

Last updatedType
06/05/2026Semi Annual Report
01/28/2026Prospectus
12/08/2025Annual Report